New hope for children with devastating genetic brain disorder

This study tested whether a drug called baricitinib could help control symptoms and slow disease progression in children with Aicardi Goutières Syndrome (AGS), a rare and severe genetic disorder. Fifty-four participants, including infants and children, took the drug for a year to see if it could stabilize or improve their neurological function and reduce harmful inflammation. The goal was to manage this lifelong condition, not cure it, as treatment would need to continue.